ICT Research: The Policy Perspective

ICT Research: The Policy Perspective
ICT for All: Technology Supporting an Inclusive World
In this report produced for the publication series ICT Research: The Policy Perspective, is explored Europe's vision for a society where every individual can make a valuable contribution. Investments in pioneering and commercially focused research will produce information and communication technologies (ICTs) that should help everyone - including the elderly, disabled and marginalised - to fulfil their potential.

There is little doubt that ICT is the key enabling technology for European society. It is vital for business and powers our financial systems. It delivers our entertainment and keeps us in touch with friends and communities. Without ICT - our computers, televisions, mobile devices, plus all the technology embedded in everyday objects - we would struggle to work, shop and travel.

So how is it, then, that almost a third of European citizens - around 150 million people - are not actively participating in this modern, high-tech society? Fewer than 15% of people aged 65 and only one in three of the unemployed regularly use the internet. About 74 million Europeans with low levels of education and a third of people in rural and remote areas remain 'unconnected'.

Download ICT Research: The Policy Perspective (.pdf, 605 KB).

Download from eHealthNews.eu Portal's mirror: ICT Research: The Policy Perspective (.pdf, 605 KB).

Content for this publication was provided by the ICT Results editorial service, working to showcase breakthrough ICT research in Europe. It is part of a series of domain surveys drawn together from articles featuring EU-funded ICT research.

For further information, please visit:
http://cordis.europa.eu/ictresults

Most Popular Now

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...